BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11302871)

  • 1. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma).
    Matucci-Cerinic M; Giacomelli R; Pignone A; Cagnoni ML; Generini S; Casale R; Cipriani P; Del Rosso A; Tirassa P; Konttinen YT; Kahaleh BM; Fan PS; Paoletti M; Marchesi C; Cagnoni M; Aloe L
    Ann Rheum Dis; 2001 May; 60(5):487-94. PubMed ID: 11302871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.
    Pignone A; Scaletti C; Matucci-Cerinic M; Vázquez-Abad D; Meroni PL; Del Papa N; Falcini F; Generini S; Rothfield N; Cagnoni M
    Clin Exp Rheumatol; 1998; 16(5):527-32. PubMed ID: 9779298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.
    Choi HJ; Shin YK; Lee HJ; Kee JY; Shin DW; Lee EY; Lee YJ; Lee EB; Song YW
    Clin Rheumatol; 2008 Apr; 27(4):437-42. PubMed ID: 17899307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of loratadine and cetirizine on serum levels of neuropeptides in patients with chronic urticaria.
    Başak PY; Vural H; Kazanoglu OO; Erturan I; Buyukbayram HI
    Int J Dermatol; 2014 Dec; 53(12):1526-30. PubMed ID: 25209952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum neurotrophin profile in systemic sclerosis.
    Lise MC; Sparsa A; Marie I; Lalloué F; Ly K; Martel C; Bezanahary H; Gondran G; Loustaud-Ratti V; Bonnetblanc JM; Vidal E; Jauberteau MO; Fauchais AL
    PLoS One; 2010 Nov; 5(11):e13918. PubMed ID: 21085492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide variability in man.
    Onuoha GN; Nugent AM; Hunter SJ; Alpar EK; McEneaney DJ; Campbell NP; Shaw C; Buchanan KD; Nicholls DP
    Eur J Clin Invest; 2000 Jul; 30(7):570-7. PubMed ID: 10886296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
    Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
    J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
    Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular autonomic function assessed by autonomic function tests and serum autonomic neuropeptides in Egyptian children and adolescents with rheumatic diseases.
    El-Sayed ZA; Mostafa GA; Aly GS; El-Shahed GS; El-Aziz MM; El-Emam SM
    Rheumatology (Oxford); 2009 Jul; 48(7):843-8. PubMed ID: 19465591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
    Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
    Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis.
    Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW
    Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
    Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
    Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
    Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
    J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suckling reduces allergic skin responses and plasma levels of neuropeptide and neurotrophin in lactating women with atopic eczema/dermatitis syndrome.
    Kimata H
    Int Arch Allergy Immunol; 2003 Dec; 132(4):380-3. PubMed ID: 14707470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor, neuropeptides and cutaneous nerves in atopic dermatitis.
    Hodeib A; El-Samad ZA; Hanafy H; El-Latief AA; El-Bendary A; Abu-Raya A
    Indian J Dermatol; 2010; 55(2):135-9. PubMed ID: 20606880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
    Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
    Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
    Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.